Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985919 · ClinicalTrials.gov registry record
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
A clinical trial of No Restrictions on Diagnosis, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT01985919: Recruiting study of No Restrictions on Diagnosis, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01985919 is a study of No Restrictions on Diagnosis that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01985919, a study of No Restrictions on Diagnosis, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical research protocol is intended to allow for bone marrow aspirate/biopsy and blood specimens to be collected for research purposes, specifically allowing subjects the option of sedation during the bone marrow procedure. Samples will be banked for future research related to cancer and other diseases. Researchers hope this protocol will improve the collection of research correlative and translational biopsy specimens for clinical research.
Conditions Studied
Interventions
- OTHER Obtaining human tissue for basic research or biospecimen bank
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2010-02-01 |
| Est. Completion | 2026-05-07 |
What NCT01985919 shows while recruiting
NCT01985919 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with No Restrictions on Diagnosis appearing as the primary indexed condition, and to 1 intervention - of which Obtaining human tissue for basic research or biospecimen bank is the first listed.
NCT01985919 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01985919 about?
NCT01985919 is a clinical study titled "Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples". This clinical research protocol is intended to allow for bone marrow aspirate/biopsy and blood specimens to be collected for research purposes, specifically allowing subjects the option of sedation during the bone marrow procedure. Samples will be banked for future research related to cancer and oth...
What is the current status of trial NCT01985919?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2010-02-01. Estimated completion is 2026-05-07.
What conditions does trial NCT01985919 study?
This clinical trial studies the following conditions: No Restrictions on Diagnosis.
What interventions are being tested in trial NCT01985919?
The interventions under investigation include: Obtaining human tissue for basic research or biospecimen bank (OTHER).
Who is sponsoring clinical trial NCT01985919?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01985919 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
- NCT02455479 · 150 participants · Phase 1
Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI